A case of pulmonary Mycobacterium malmoense infection presenting as a pseudotumour of the lung in a severely immunosuppressed HIV infected patient is reported.
In June 1985 a 27 year old homosexual man presented with generalised lymphadenopathy and was diagnosed HIV antibody positive. He remained well until May 1987 when he developed angular cheilitis, folliculitis, and oral hairy leucoplakia. In March 1988 he had been given zidovudine and co-trimoxazole in view of his persistently low CD4 count of less than 200 cells/Il. Anaemia and neutropenia de- veloped which resolved after stopping these drugs. Nebulised pentamidine was substituted for co-trimoxazole. He was later rechallenged with low dose zidovudine but his anaemia recurred. His compliance with nebulised pentamidine was poor, and in October 1990 he had an episode of bronchoscopically confirmed Pneumocystis carinii pneumonia. He was treated with standard high dose co-trimoxazole and made a full recovery.
In May 1991 he complained of left pleuritic chest pain, low grade fever, and weight loss. His chest radiograph showed a confluent area of consolidation in the left upper zone (fig 1) , a lateral film indicating involvement of the apical segment of the left lower lobe. His CD4 lymphocyte count at this time was 25 cells/Id.
No bacterial pathogens were found in the sputum which was also repeatedly negative for acid fast bacilli. Viral titres and an atypical pneumonia screen were negative. He was initially treated with erythromycin and amoxycillin but, because of persistent symptoms and worsening of his chest radiograph, his treatment was changed to ciprofloxacin 750 mg twice daily and he improved clinically.
A month later he was readmitted with frank haemoptysis. His chest radiograph showed that there was now cavitation within the left upper zone shadowing (fig 2) . Bronchoscopic examination showed a white necrotic tumourlike mass occluding the apical segment of the left lower lobe which looked like a carcinoma of the bronchus. Bronchial lavage contained no malignant cells or acid fast bacilli but a biopsy of the "tumour" showed numerous macrophages filled with acid fast bacilli. Mycobacterium malmoense was cultured from the biopsy specimen and was sensitive to ethambutol, rifampicin, streptomycin, and ciprofloxacin, but resistant to isoniazid and pyrazinamide. He was treated with rifampicin, ethambutol, and ciprofloxacin and became asymptomatic.
Eight months later, whilst he was continuing full antimycobacterial treatment, he developed left pleuritic chest pain and breathlessness. His chest radiograph was unchanged compared with that of the previous admission. A repeat bronchoscopy was carried out by the same bronchoscopist who found no change from the previous findings. A repeat biopsy was taken from the endobronchial "tumour" occluding the apical segment of the lower lobe. Culture of this biopsy tissue grew M malmoense. The patient's symptoms settled on analgesia alone, and for the present he remains well and free of haemoptysis on antimycobacterial treatment. Although tuberculosis can present with tumour-like masses in the lung, this is, to our knowledge, the first reported case of M malmoense mimicking bronchial carcinoma endoscopically. Eight months after the first bronchoscopy there appeared to be little change in "tumour" bulk and its growth may have been checked by the prolonged antimycobacterial treatment. Although the patient responded clinically, it is intended to treat him lifelong as he did not achieve any radiological or bronchoscopial response. The optimum treatment for M malmoense infection in HIV antibody positive patients has not been established. In HIV negative patients Banks et al6 obtained the best results with rifampicin, ethambutol, and isoniazid for periods of between 18 and 24 months. Surgical resection which has been successful in four HIV negative patients6 would be possible in this case as the disease appears to be localised. Nevertheless, this patient is only mildly symptomatic and the risk of operation probably outweighs any long term benefits as he is severely immunosuppressed. His prognosis is directly related to his degree of immunosuppression and whether or not he develops any life threatening diseases.
Mycobacterium malmoense infection appears to occur at a late stage of HIV disease when the CD4 count is below 50 cells/!l. Unlike the M avium complex, where systemic infection is common and prognosis poor in HIV positive patients, M malmoense appears to be confined to the lung and its course is indolent. Swallowed infected sputum may have caused the positive stool culture in one of the patients reported by Claydon et al. 7 As the HIV epidemic continues to evolve, clinicians may well be challenged by unusual presentations of atypical mycobacterial disease and face difficult treatment decisions.
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